doxycycline 40 mg modified Oracea
Selected indexed studies
- Rosacea. (Br J Hosp Med (Lond), 2021) [PMID:33646026]
- Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. (Lancet Infect Dis, 2024) [PMID:38797183]
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. (Br J Dermatol, 2019) [PMID:30585305]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rosacea. (2021) pubmed
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. (2019) pubmed
- Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. (2024) pubmed
- Long-term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified-release capsules once daily. (2022) pubmed
- Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials. (2025) pubmed
- Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. (2016) pubmed
- Doxycycline-encapsulated nanotube-modified dentin adhesives. (2014) pubmed
- Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study. (2015) pubmed
- A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. (2020) pubmed
- Efficacy of Subantimicrobial, Modified-Release Doxycycline Compared to Regular-Release Doxycycline for the Treatment of Hidradenitis Suppurativa. (2022) pubmed